News On Japan

Japan approves its first homemade oral COVID drug

TOKYO, Nov 23 (Nikkei) - Japan's health ministry on Tuesday granted emergency use of a COVID-19 drug developed by Shionogi, making it the country's first domestically produced oral medicine for patients with mild symptoms. The drug is expected to be available for use in early December.

The ministry says the drug, Xocova, is effective in speeding up recovery from symptoms. According to data Shionogi released from the final stage of its clinical trials in September, patients who took the drug once a day for five straight days recovered from symptoms such as runny noses and high temperatures in seven, rather than eight days. A fall in virus load was also reported.

Japan's Ministry of Health, Labor and Welfare has signed a contract with Shionogi to supply the drugs for 1 million people.

In anticipation of a new wave of infection, the drug will likely be supplied to hospitals and clinics as soon as possible. Supply will be stable given that the drug is produced in Japan. Children under the age of 12 and pregnant women or women of childbearing potential cannot use it. ...continue reading

News On Japan
POPULAR NEWS

The first auction of the season signaling the arrival of new tea was held on the morning of April 18th at the Shizuoka Tea Market in Shizuoka City, with the highest bid reaching 880,000 yen per kilogram, continuing the trend of high prices into 2025.

Prime Minister Ishiba has clarified his stance on ongoing trade negotiations with the Trump administration, stating that security and trade are separate matters and that discussions on security should not be linked to tariffs.

Japanese astronaut Takuya Onishi has been appointed commander of the International Space Station (ISS), becoming the third Japanese to assume the role.

Transportation of a 150-meter railway rail—the longest in the world—manufactured at a steelworks in Kitakyushu City, began on April 18th. The rail will be delivered to Hokkaido over the course of about four days for use in the Hokkaido Shinkansen extension project.

The Japan Society for the Study of Obesity has issued a warning about the health risks of excessive thinness and poor nutrition among women, positioning what it calls 'women's underweight and malnutrition syndrome' as a newly recognized health condition.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

A new treatment for Parkinson's disease using iPS cells developed by Kyoto University has shown a certain level of effectiveness in clinical trials.

Concerns are mounting over the discovery of illegal radio signals believed to originate from "fake base stations" mimicking cell towers in Tokyo and Osaka, with experts warning of the risk of personal data theft and potential fraud.

Pelvic organ prolapse is a condition affecting a significant number of women over the age of 40, yet remains largely under-recognized. It occurs when organs in the pelvic region, such as the bladder or uterus, descend due to weakened support muscles, often as a result of childbirth or aging.

As the new school term begins, a concerning trend is emerging with whooping cough—caused by the Bordetella pertussis bacterium—spreading across Japan and posing a potentially life-threatening risk, especially to infants who may suffer severe complications or even death from persistent coughing fits.

A new treatment using iPS cells, known for their ability to transform into any type of cell in the body, is poised to become the first of its kind in the world. A venture from Osaka University has applied to the Ministry of Health, Labor and Welfare for approval to manufacture and market the innovative therapy.

Construction of the Hokkaido Shinkansen extension to Sapporo reached a major milestone on April 8th with the breakthrough of the Nodao Tunnel in Yakumo Town, southern Hokkaido, after 10 years of work.

A museum dedicated to rockets and space has opened in Kushimoto, Wakayama Prefecture, home to Japan's first private rocket launch site.

The Japanese government has released an updated damage forecast for a potential Nankai Trough megaquake, estimating that up to 298,000 people could die in the worst-case scenario. This projection reflects a slight reduction from the previous estimate of 332,000 deaths made 13 years ago.